Pharmacokinetics and Safety of Single Oral Doses of Emtricitabine in Human Immunodeficiency Virus-Infected Children
Laurene H. Wang(Triangle), Patricia M. Flynn(St. Jude Children's Research Hospital), Saroj Bakshi(North Shore University Hospital), Mobeen H. Rathore, Andrew Wiznia(Jacobi Medical Center), Gregory E. Chittick(Chimerix (United States)), Patricia Emmanuel(University of South Florida)
Cited by 46
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
|Nature Medicine|1999|580